Profile
Allyson S.
Rinderle is currently a Director at Paige LLC, PetVet Care Centers LLC, and a Managing Director at Bain Capital Life Sciences LP.
She is also a Board Advisor at Blavatnik Fund For Innovation At Yale University.
Previously, she worked as a Director at Impel Pharmaceuticals, Inc. and Envision Healthcare Corp., an Analyst at Aisling Capital LLC and J.P.
Morgan & Co., Inc. (Old), a Principal at Kohlberg Kravis Roberts & Co. LP, and a Vice President at Longitude Capital Management Co LLC.
She holds an MBA from Stanford University and an undergraduate degree from Yale University.
Allyson S. Rinderle active positions
| Companies | Position | Start |
|---|---|---|
PetVet Care Centers LLC
PetVet Care Centers LLC Agricultural Commodities/MillingProcess Industries Operates veterinary hospitals | Director/Board Member | - |
Paige LLC
Paige LLC TextilesProcess Industries Designs, manufactures, and markets denim & apparel for men and women through online | Director/Board Member | - |
Bain Capital Life Sciences LP
Bain Capital Life Sciences LP Investment ManagersFinance Bain Capital Life Sciences invests in both public and private companies located around the world. The firm focuses on sectors such as biopharmaceutical, specialty pharmaceuticals, medical devices, diagnostics, and life science technology. It participates in late and growth stage capital requirements with an investment size of USD 25 million - 100 million. | Private Equity Investor | 2022-09-30 |
Blavatnik Fund For Innovation At Yale University | Consultant / Advisor | - |
Former positions of Allyson S. Rinderle
| Companies | Position | End |
|---|---|---|
Kohlberg Kravis Roberts & Co. LP
Kohlberg Kravis Roberts & Co. LP Investment ManagersFinance KKR invests in middle market private and public companies located across the globe with an enterprise value of USD 200 - 1000 million. The firm focuses on companies operating across a broad range of sectors and industries. It provides financing for equity, buyouts, acquisitions, debt and growth capital requirements. It makes minority and majority investments and also makes follow on investments and co-investments.. | Private Equity Investor | 2022-09-29 |
Longitude Capital Management Co LLC
Longitude Capital Management Co LLC Investment ManagersFinance Longitude Capital invests in both private and public companies located in the United States. The firm targets companies operating in the fields of medical technology, biotechnology and health solutions. It participates in early stage capital requirements. | Private Equity Investor | 2017-07-30 |
Aisling Capital LLC
Aisling Capital LLC Investment ManagersFinance Aisling Capital invests in both private and public companies located in the Unites States. The firm targets companies operating in the fields of developing & commercializing important and innovative healthcare products, services & technologies sectors and industries. It provides financing for royalty deals, large cap leveraged buyout, seed, early and late stage capital requirements in the form of equity and debt. | Private Equity Analyst | 2014-06-29 |
| IPI LEGACY LIQUIDATION CO | Director/Board Member | - |
| ENVISION HEALTHCARE CORPORATION | Director/Board Member | - |
Training of Allyson S. Rinderle
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 12 |
|---|---|
Aisling Capital LLC
Aisling Capital LLC Investment ManagersFinance Aisling Capital invests in both private and public companies located in the Unites States. The firm targets companies operating in the fields of developing & commercializing important and innovative healthcare products, services & technologies sectors and industries. It provides financing for royalty deals, large cap leveraged buyout, seed, early and late stage capital requirements in the form of equity and debt. | Finance |
Impel Pharmaceuticals, Inc.
Impel Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a late-stage biopharmaceutical company focused on developing transformative therapies for central nervous system disorders | Health Technology |
Stanford University
Stanford University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Kohlberg Kravis Roberts & Co. LP
Kohlberg Kravis Roberts & Co. LP Investment ManagersFinance KKR invests in middle market private and public companies located across the globe with an enterprise value of USD 200 - 1000 million. The firm focuses on companies operating across a broad range of sectors and industries. It provides financing for equity, buyouts, acquisitions, debt and growth capital requirements. It makes minority and majority investments and also makes follow on investments and co-investments.. | Finance |
J.P. Morgan & Co., Inc. (Old)
J.P. Morgan & Co., Inc. (Old) Regional BanksFinance Provides commercial banking and investment advisory services | Finance |
Yale University
Yale University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Paige LLC
Paige LLC TextilesProcess Industries Designs, manufactures, and markets denim & apparel for men and women through online | Process Industries |
Longitude Capital Management Co LLC
Longitude Capital Management Co LLC Investment ManagersFinance Longitude Capital invests in both private and public companies located in the United States. The firm targets companies operating in the fields of medical technology, biotechnology and health solutions. It participates in early stage capital requirements. | Finance |
PetVet Care Centers LLC
PetVet Care Centers LLC Agricultural Commodities/MillingProcess Industries Operates veterinary hospitals | Process Industries |
Envision Healthcare Corp.
Envision Healthcare Corp. Medical/Nursing ServicesHealth Services Provides physician and healthcare services | Health Services |
Bain Capital Life Sciences LP
Bain Capital Life Sciences LP Investment ManagersFinance Bain Capital Life Sciences invests in both public and private companies located around the world. The firm focuses on sectors such as biopharmaceutical, specialty pharmaceuticals, medical devices, diagnostics, and life science technology. It participates in late and growth stage capital requirements with an investment size of USD 25 million - 100 million. | Finance |
Blavatnik Fund For Innovation At Yale University |
- Stock Market
- Insiders
- Allyson S. Rinderle
















